Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2016 Nov 28;35:185. doi: 10.1186/s13046-016-0459-z

Erratum to: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer

Andrea Prodosmo 1, Amelia Buffone 4, Manlio Mattioni 1, Agnese Barnabei 3, Agnese Persichetti 3,4, Aurora De Leo 3, Marialuisa Appetecchia 3, Arianna Nicolussi 11, Anna Coppa 11, Salvatore Sciacchitano 5, Carolina Giordano 6, Paola Pinnarò 6, Giuseppe Sanguineti 6, Lidia Strigari 7, Gabriele Alessandrini 8, Francesco Facciolo 8, Maurizio Cosimelli 9, Gian Luca Grazi 9, Giacomo Corrado 10, Enrico Vizza 10, Giuseppe Giannini 2,4,, Silvia Soddu 1,
PMCID: PMC5127086  PMID: 27894319

Erratum

In original publication of this article [1], the data for “Pat#7” in Additional file 1 was listed as “c.4436+24G>A” in the “Nucleotide change” column. Instead, the number should have been c.4436+24A>G.

Additional file

Additional file 1: (16.3KB, docx)

Characteristics of ATM variants. (DOCX 16 kb)

Footnotes

The online version of the original article can be found under doi:10.1186/s13046-016-0410-3.

The online version of the original article can be found at http://dx.doi.org/10.1186/s13046-016-0410-3.

Contributor Information

Giuseppe Giannini, Email: giuseppe.giannini@uniroma1.it.

Silvia Soddu, Email: silvia.soddu@ifo.gov.it.

Reference

  • 1.Prodosmo A, et al. Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer. J Exp Clin Cancer Res. 2016;35:135. doi: 10.1186/s13046-016-0410-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES